Known as the "weight loss injection," Ozempic was initially designed for Type 2 diabetes treatment. Like other medications sold under the Wegovy and Rybelsus brands, its active ingredient is semaglutide. Semaglutide helps regulate blood sugar levels and assists in appetite control.
Administered weekly.
Each dose provides 6-7 days of satiety, with effects accumulating over time.
Side effects may include vomiting, diarrhea, and nausea, indicating gastrointestinal discomfort.
It may reduce cravings for fatty foods.
Studies have shown:
Consumption of fatty foods decreases.
86% of participants achieved successful weight loss.
13% lost 1-4 kg in one month,
66% lost 5-7 kg,
17% lost 8-11 kg,
4% lost over 12 kg in one month.
On average, a weight loss of 15% of body weight is achievable. However, consult your doctor if side effects like stomach pain or yellowing of the skin or eyes are observed. Additionally, the risk of cardiovascular diseases among users was reduced by 26%.
